219
Views
0
CrossRef citations to date
0
Altmetric
Review

Myocardial healing using cardiac fat

, &
Pages 305-311 | Received 21 Nov 2017, Accepted 04 Mar 2018, Published online: 14 Mar 2018

References

  • Olivetti G, Capasso JM, Meggs LG, et al. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res. 1991;68:856–869.
  • Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763–776.
  • Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA. 2003;100:12313–12318.
  • Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann NY Acad Sci. 2001;938:221–229.
  • Behfar A, Yamada S, Crespo-Diaz R, et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010;56:721–734.
  • Roura S, Gálvez-Montón C, Bayes-Genis A. The challenges for cardiac vascular precursor cell therapy: lessons from a very elusive precursor. J Vasc Res. 2013;50:304–323.
  • Roura S, Gálvez-Montón C, Mirabel C, et al. Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario? Stem Cell Res Ther. 2017;8:238.
  • Bayés-Genís A, Gálvez-Montón C, Roura S. Cardiac tissue engineering: lost in translation or ready for translation? J Am Coll Cardiol. 2016;68:724–726.
  • Ma H, Liu J, Qian L. Fat for fostering: regenerating injured heart using local adipose tissue. eBioMedicine. 2016;7:25.6.
  • Bayes-Genis A, Gastelurrutia P, Cámara ML, et al. First-in-man safety and efficacy of the adipose graft transposition procedure (AGTP) in patients with a myocardial scar. EBioMedicine. 2016;7:248–254.
  • Gastelurrutia P, Gálvez-Montón C, Cámara ML, et al. Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial. BMJ Open. 2017;7:e017187.
  • Frese L, Dijkman PE, Hoerstrupa SP. Adipose tissue-derived stem cells in regenerative medicine. Transfus Med Hemother. 2016;43:268–274.
  • Digirolamo CM, Stokes D, Colter D, et al. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 1999;107:275–281.
  • Sterodimas A, De Faria J, Nicaretta B, et al. Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg. 2010;63:1886–1892.
  • Houtgraaf JH, Den Dekker WK, Van Dalen BM, et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59:539–540.
  • Perin EC, Sanz-Ruiz R, Sánchez PL, et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE trial. Am Heart J. 2014;168(88–95):e82.
  • Qayyum AA, Haack-Sørensen M, Mathiasen AB, et al. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regen Med. 2012;7:421–428.
  • Caplan AI. Mesenchymal stem cells: time to change the name! Stem Cells Transl Med. 2017;6:1445–1451.
  • Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907–917.
  • Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88:5163–5168.
  • Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–2466.
  • Bayes-Genis A, Soler-Botija C, Farré J, et al. Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J Mol Cell Cardiol. 2010;49:771–780.
  • Perea-Gil I, Monguió-Tortajada M, Gálvez-Montón C, et al. Preclinical evaluation of the immunomodulatory properties of cardiac adipose tissue progenitor cells using umbilical cord blood mesenchymal stem cells: a direct comparative study. Biomed Res Int. 2015;2015:439808.
  • Severs NJ. The cardiac muscle cell. Bioessays. 2000;22:188–199.
  • Vogel V, Sheetz M. Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol. 2006;7:265–275.
  • Available from: https://vimeo.com/223293168.
  • Llucià-Valldeperas A, Sanchez B, Soler-Botija C, et al. Electrical stimulation of cardiac adipose tissue-derived progenitor cells modulates cell phenotype and genetic machinery. J Tissue Eng Regen Med. 2015;9:E76–83.
  • Llucià-Valldeperas A, Soler-Botija C, Gálvez-Montón C, et al. Electromechanical conditioning of adult progenitor cells improves recovery of cardiac function after myocardial infarction. Stem Cells Transl Med. 2017;6:970–981.
  • Llucià-Valldeperas A, Bragós R, Soler-Botija C, et al. Unravelling the effects of mechanical physiological conditioning on cardiac adipose tissue-derived progenitor cells in vitro and in silico. Sci Rep. 2018;8:499.
  • Prat-Vidal C, Gálvez-Montón C, Puig-Sanvicens V, et al. Online monitoring of myocardial bioprosthesis for cardiac repair. Int J Cardiol. 2014;174:654–661.
  • Gálvez-Montón C, Bragós R, Soler-Botija C, et al. Noninvasive assessment of an engineered bioactive graft in myocardial infarction: impact on cardiac function and scar healing. Stem Cells Transl Med. 2017;6:647–655.
  • Perea-Gil I, Uriarte JJ, Prat-Vidal C, et al. In vitro comparative study of two decellularization protocols in search of an optimal myocardial scaffold for recellularization. Am J Transl Res. 2015;7:558–573.
  • Perea-Gil I, Prat-Vidal C, Gálvez-Montón C, et al. A cell-enriched engineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model. JACC Basic Transl Med. 2016;1:360–372.
  • Gálvez-Montón C, Fernandez-Figueras MT, Martí M, et al. Neoinnervation and neovascularization of acellular pericardial-derived scaffolds in myocardial infarcts. Stem Cell Res Ther. 2015;6:108.
  • Guadix JA, Zugaza JL, Gálvez-Martín P. Characteristics, applications and prospects of mesenchymal stem cells in cell therapy. Med Clin (Barc). 2017;148:408–414.
  • Lechanteur C, Briquet A, Giet O, et al. Clinical-scale expansion of mesenchymal stromal cells: a large banking experience. J Transl Med. 2016;14:145.
  • Torre ML, Lucarelli E, Guidi S, et al. Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application. Stem Cells Dev. 2015;24:677–685.
  • Vives J, Oliver-Vila I, Pla A. Quality compliance in the shift from cell transplantation to cell therapy in non-pharma environments. Cytotherapy. 2015;17:1009–1014.
  • Ikebe C, Suzuki K. Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols. Biomed Res Int. 2014;2014:951512.
  • Capelli C, Pedrini O, Valgardsdottir R, et al. Clinical grade expansion of MSCs. Immunol Lett. 2015;168:222–227.
  • Tarte K, Gaillard J, Lataillade JJ, et al. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood. 2010;115:1549–1553.
  • Garcia S, Bernad A, Martín MC, et al. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res. 2010;316:1648–1650.
  • Stultz BG, McGinnis K, Thompson EE, et al. Chromosomal stability of mesenchymal stromal cells during in vitro culture. Cytotherapy. 2016;18:336–343.
  • Binato R, de Souza Fernandez T, Lazzarotto-Silva C, et al. Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy. Cell Prolif. 2013;46:10–22.
  • Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy. J Transl Med. 2011;9:29.
  • Gálvez-Montón C, Prat-Vidal C, Roura S, et al. Transposition of a pericardial-derived vascular adipose flap for myocardial salvage after infarct. Cardiovasc Res. 2011;91:659–667.
  • Gálvez-Montón C, Prat-Vidal C, Roura S, et al. Post-infarction scar coverage using a pericardial-derived vascular adipose flap. pre-clinical results. Int J Cardiol. 2013;166:469–474.
  • Gálvez-Montón C, Gastelurrutia P, Diaz-Güemes I, et al. Minimally invasive adipose graft transposition procedure. J Cardiovasc Trans Res. 2017;10:66–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.